Stem Cells Translational Medicine · 2018 · 44 citations · 30 references
EngineeringBioengineeringBiomedical EngineeringBiocompatibilityBone MetabolismTissue EngineeringBone Tissue EngineeringCell-scaffold InteractionsMesenchymal Stem Cell TherapyMesenchymal Stromal Cell TherapyRegenerative ScaffoldsTissue Engineering ScaffoldsBiomimetic ScaffoldsBone Marrow-derived Mesenchymal Stromal CellsCell-seeded ScaffoldsMagnesium-doped HydroxyapatiteMesenchymal Stem Cell SeedingRankl SignalingRankl-mediated OsteoclastogenesisStem Cell-seeded Scaffolds
Abstract Biomimetic scaffolds are extremely versatile in terms of chemical composition and physical properties, which can be defined to accomplish specific applications. One property that can be added is the production/release of bioactive soluble factors, either directly from the biomaterial, or from cells embedded within the biomaterial. We reasoned that pursuing this strategy would be appropriate to setup a cell-based therapy for RANKL-deficient autosomal recessive osteopetrosis, a very rare skeletal genetic disease in which lack of the essential osteoclastogenic factor RANKL impedes osteoclast formation. The exogenously administered RANKL cytokine is effective in achieving osteoclast formation and function in vitro and in vivo, thus, we produced murine Rankl−/− mesenchymal stromal cells (MSCs) overexpressing human soluble RANKL (hsRL) following lentiviral transduction (LVhsRL). Here, we described a three-dimensional (3D) culture system based on a magnesium-doped hydroxyapatite/collagen I (MgHA/Col) biocompatible scaffold closely reproducing bone physicochemical properties. MgHA/Col-seeded murine MSCs showed improved properties, as compared to two-dimensional (2D) culture, in terms of proliferation and hsRL production, with respect to LVhsRL-transduced cells. When implanted subcutaneously in Rankl−/− mice, these cell constructs were well tolerated, colonized by host cells, and intensely vascularized. Of note, in the bone of Rankl−/− mice that carried scaffolds with either WT or LVhsRL-transduced Rankl−/− MSCs, we specifically observed formation of TRAP+ cells, likely due to sRL released from the scaffolds into circulation. Thus, our strategy proved to have the potential to elicit an effect on the bone; further work is required to maximize these benefits and achieve improvements of the skeletal pathology in the treated Rankl−/− mice. Stem Cells Translational Medicine 2019;8:22–34
30
Evidence for osteocyte regulation of bone homeostasis through RANKL expression
Tomoki Nakashima, Mikihito Hayashi, Takanobu Fukunaga et al. · Nature Medicine · 2011 · 1.7K citations
Medicine, Cell Biology, Physiology +16
Matrix-embedded cells control osteoclast formation
Jinhu Xiong, Melda Onal, Robert L. Jilka et al. · Nature Medicine · 2011 · 1.3K citations · Full text
Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL
Cristina Sobacchi, Annalisa Frattini, Matteo M. Guerrini et al. · Nature Genetics · 2007 · 387 citations
Structure and properties of bilayer chitosan–gelatin scaffolds
Jin Shu Mao, Li Guo Zhao, Yu Yin · Biomaterials · 2002 · 372 citations